Skip to main content

Table 4 Annualized adjusted total excess cost of community acquired pneumonia by selected comorbidity group

From: Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults

Type of excess cost

 

All Patients

No key comorbidity

Comorbid group

    

Asthma

Diabetes

COPD

CHF

Total medical

Mean

$11,395

$9,866

$10,158

$16,351

$17,039

$31,593

 

(SE)

($42)

($43)

($109)

($165)

($186)

($531)

 

(95% CI)

($11,312, $11,477)

($9,782, $9,951)

($9,945, $10,371)

($16,027, $16,674)

($16,674, $17,404)

($30,553, $32,634)

Total productivity costs

Mean

$3,034

$2,734

$3,149

$5,044

$6,454

$2,842

 

(SE)

($55)

($45)

($272)

($263)

($329)

($752)

 

(95% CI)

($2,927, $3,141)

($2,645, $2,823)

($2,616, $3,681)

($4,528, $5,561)

($5,810, $7,098)

($1,369, $4,316)

Total cost

Mean

$14,429

$12,601

$13,307

$21,395

$23,493

$34,436

 

(SE)

($44)

($44)

($123)

($171)

($197)

($549)

 

(95% CI)

($14,343, $14,514)

($12,514, $12,687)

($13,066, $13,548)

($21,061, $21,730)

($23,106, $23,880)

($33,360, $35,511)

Total cost relative to patients without selected comorbidities

 

1.15

1.00

1.06

1.70

1.86

2.73

  1. Abbreviation: COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure; SE, standard error; CI: confidence interval.
  2. Note: comorbid groups are not mutually exclusive. Cost estimates are from generalized linear regressions.
  3. All excess cost estimates are significant at p<0.01.